ROBUST QUICK-PRODUCTION ARTIFICIAL VENTILATOR

The CoVid-19 disease stands out due to severe pulmonary involvement in a percentage of 20%, in patients with a confirmed diagnosis of the virus. Within this group of patients, between 5% -15% require admission to the different Intensive Care Units. In 80% of those admitted to them, invasive mechanical ventilation is the only treatment support measure for the developed pathology, known as Acute Respiratory Distress Syndrome (ARDS). The massive penetration of CoVid-19 in the population has caused the demand for respirators to perform mechanical ventilation to skyrocket worldwide. Growth has been so rapid and sudden that providers are unable to meet demand, and as a consequence there is a shortage of ventilators for treating patients in countries suffering from this pandemic. In many countries, the absence of respirators to treat patients affected by ARDS is causing an increase in mortality, as well as in the frequency of the appearance of serious secondary injuries. The present invention tries to solve the above problems by designing a respirator through an artificial respirator specially designed to allow rapid manufacturing and with readily available components that, at the same time, maintains a robustness of operation compatible with the treatment of patients. with severe respiratory failure. This new ventilator is indicated to provide invasive mechanical ventilation to patients requiring full ventilation support. Its programming allows to achieve positive pressure values ??at the end of expiration (PEEP) between 10 and 20 cmH2O, VT> 100 ml / kg and plateau pressures lower than 40 cmH2O, as well as values ??of the inspiration / expiration (I / E) ratio 1 : 1, 1: 2, 1: 3, 2: 1, 2: 2 and 2: 3, and respiratory rate parameters from 10 to 40 breaths per minute.